PIA
GILD icon

Piedmont Investment Advisors’s Gilead Sciences GILD Stock Holding History

Piedmont Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-109,024
Closed -$8.15M – 276
2020
Q1 		$8.15M Buy
109,024
+68,499
+169% +$4.73M 0.32% 68
2019
Q4 		$2.63M Sell
40,525
-62,229
-61% -$4.05M 0.09% 187
2019
Q3 		$6.51M Buy
102,754
+5,318
+5% +$348K 0.25% 101
2019
Q2 		$6.58M Sell
97,436
-57,448
-37% -$3.78M 0.26% 94
2019
Q1 		$10.1M Buy
154,884
+837
+0.5% +$55.6K 0.41% 51
2018
Q4 		$9.64M Buy
154,047
+6,848
+5% +$479K 0.46% 43
2018
Q3 		$11.4M Buy
147,199
+91,254
+163% +$6.89M 0.48% 42
2018
Q2 		$3.96M Sell
55,945
-140,632
-72% -$9.93M 0.19% 123
2018
Q1 		$14.8M Sell
196,577
-85,475
-30% -$6.79M 0.4% 60
2017
Q4 		$20.2M Sell
282,052
-76,411
-21% -$5.8M 0.41% 60
2017
Q3 		$29M Buy
358,463
+37,969
+12% +$2.9M 0.62% 41
2017
Q2 		$22.7M Buy
320,494
+38,040
+13% +$2.53M 0.5% 47
2017
Q1 		$19.2M Buy
282,454
+2,410
+0.9% +$169K 0.4% 69
2016
Q4 		$20.1M Buy
280,044
+7,102
+3% +$528K 0.41% 71
2016
Q3 		$21.6M Sell
272,942
-406,173
-60% -$33M 0.47% 62
2016
Q2 		$56.7M Buy
679,115
+20,634
+3% +$1.83M 1.17% 21
2016
Q1 		$60.5M Sell
658,481
-18,782
-3% -$1.69M 1.27% 17
2015
Q4 		$68.5M Buy
677,263
+43,764
+7% +$4.55M 1.45% 15
2015
Q3 		$62.2M Sell
633,499
-45,718
-7% -$5.08M 1.4% 13
2015
Q2 		$79.5M Buy
679,217
+306,307
+82% +$33.5M 1.68% 7
2015
Q1 		$36.6M Buy
372,910
+63,910
+21% +$6.49M 2.24% 12
2014
Q4 		$29.1M Buy
309,000
+202,084
+189% +$20.9M 1.76% 25
2014
Q3 		$11.4M Buy
+106,916
New +$10.5M 0.59% 45
2013
Q4 		– Sell
-1,186
Closed -$74.6K – 352
2013
Q3 		$74.6K Hold
1,186
– – ﹤0.01% 157
2013
Q2 		$60.8K Buy
+1,186
New +$61.8K ﹤0.01% 219

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Piedmont Investment Advisors's GILD Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 109,024 shares — an estimated $8.15M sold.

Piedmont Investment Advisors first reported a position in GILD in Q2 2013 and held it in 25 quarters. The position peaked at $79.5M in Q2 2015. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 109,024 Gilead Sciences shares in Q2 2020, an estimated $8.15M.
  • Piedmont Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 25 quarters.
  • Piedmont Investment Advisors's Gilead Sciences position peaked at $79.5M in Q2 2015.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.